Short answer
CME Group (CME) filed its Q3 2026 10-Q quarterly report on Oct 23, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.7B (up 13.0% year over year) with net income of $1.0B.
Q3 2026 key financials · XBRL
- Revenue
- $1.7B
- +13.0% YoY · +1.8% QoQ
- Net income
- $1.0B
- +15.6% YoY · +0.9% QoQ
- Operating margin
- 65.7%
- EPS (diluted)
- $2.90
- +16.5% YoY · +0.7% QoQ
Source: XBRL data from the CME Group (CME) Q3 2026 10-Q on SEC EDGAR. USD.
CME Group Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,737.3M, up from $1,537.6M YoY, with clearing and transaction fees $1,378.1M vs $1,227.9M
- Operating margin 65.7% vs 63.3% YoY, net income $1,036.9M vs $908.0M
- Strongest product line: interest rates, average daily volume 15,121 vs 13,378 thousand
- Weakest product line: cryptocurrency, contract volumes decreased versus the third quarter of 2025
- Operating cash flow $3,292.9M vs $3,143.2M, cash $2.2B vs $4.4B at December 31, 2025, share repurchase authorization remaining $1.0B
Risk Factors
- No material changes to risk factors since the December 31, 2025 Form 10-K
- Carried-forward risks remain the principal regulatory, operational, market and financial exposures identified in the 10-K
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CME Group quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.